Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRINOX and SBRT for Locally Advanced Pancreatic Cancer
NCT02128100Phase 2Completed
- Sponsor
- University of Louisville
- Start
- Sep 2014
- Primary completion
- Mar 2021
- Modality
- Nanoparticles, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, folinic acid, irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab, fluorouracil in pancreatic cancer (PC), sponsored by University of Louisville. Started Sep 2014; status: completed.
02
Drugs
oxaliplatinfolinic acidirinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumabfluorouracil
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02128100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128100.